Montelukast Prescribing at RYDAL
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
599
Total Quantity
21.1K
NHS Cost
£1.1K
vs National Avg
-12.5%
RYDAL prescribed 599 items of Montelukast over the last 12 months at a cost of £1,085 to the NHS. This is 12.5% below the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jun 2026
48
Jun 2026
47
Jun 2026
36
Jun 2026
41
Jun 2026
63
Jun 2026
39
Jun 2026
59
Jun 2026
59
Jun 2026
43
Jun 2026
57
Jun 2026
51
Jun 2026
56
Prescribing Details
| Total Items | 599 |
|---|---|
| Total Quantity | 21,073 |
| Total NHS Cost | £1,085 |
| Presentations | 4 different forms |
| vs National Average | -12.5% |
Montelukast Prescribing Comparison
| This practice | 599 items |
|---|---|
| National average per practice | 685 items |
| Difference | -12.5% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.